For healthcare professionals only


Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmö trial

BMJ 2006; 332 doi: (Published 23 March 2006) Cite this as: BMJ 2006;332:727
  1. Per-Henrik Zahl, senior statistician (,
  2. Jan Mæhlen, professor
  1. Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403, Oslo, Norway
  2. Department of Pathology, Ullevål University Hospital, N-0407 Oslo

    EDITOR—In their follow-up of the Malmö mammography trial, Zackrisson et al say that the reported levels of overdiagnosis vary from 5% to 50%.1 However, to use cumulative incidence rates at the end of follow-up to quantify the level of overdiagnosis is confusing because the resulting estimates are highly sensitive to both the length of follow-up and the length of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription